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Hormonal variation over the menstrual cycle alters women’s preferences for 1 
phenotypic indicators of men’s genetic or parental quality. Hormonal contraceptives 2 
suppress these shifts, inducing different mate preference patterns amongst users and 3 
non-users. This raises the possibility that women using oral contraception choose 4 
different partners than they would do otherwise but, to date, we know neither whether 5 
these laboratory-measured effects are sufficient to exert real-world consequences, nor 6 
what these consequences would be. Here we test for differences in relationship quality 7 
and survival between women who were using or not using oral contraception when 8 
they chose the partner who fathered their first child. Women who used oral 9 
contraception scored lower on measures of sexual satisfaction and partner attraction, 10 
experienced increasing sexual dissatisfaction during the relationship, and were more 11 
likely to be the one to initiate an eventual separation if it occurred. However, the same 12 
women were more satisfied with their partner’s paternal support, and thus had longer 13 
relationships and were less likely to separate. These effects are congruent with 14 
evolutionary predictions based on cyclical preference shifts. Our results demonstrate 15 
that widespread use of hormonal contraception may contribute to relationship 16 
outcome, with implications for human reproductive behaviour, family cohesion, and 17 
quality of life.  18 
 19 
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1. INTRODUCTION 24 
Women express an increased periovulatory preference for traits that signal genetic 25 
quality or compatibility [1-4]. Hormonal contraceptives suppress these shifts, leading 26 
to different mate preference patterns amongst users and non-users [5-8] and changes 27 
in women’s preferences before and after initiating use [9]. To date, this evidence 28 
comes from laboratory studies, but it suggests that hormonal contraceptive users 29 
might make different actual partner choices than they otherwise would [9-12]. 30 
Because oral contraceptives are widely used (e.g. 82% of women in the United States  31 
have used them at some time [13] and 40-54% of women aged 16-34 currently use 32 
them in the UK [14]), such effects could be substantial and widespread. 33 
 Research on mate preferences for genetic complementarity at the major 34 
histocompatibility complex (MHC) has provided the clearest evidence for these 35 
effects. If preferences are typically for MHC-dissimilar partners [8,10], and use of 36 
oral contraceptives shifts preferences towards MHC-similarity [9], then couples who 37 
meet while the woman is using hormonal contraception may be more likely to be 38 
relatively MHC-similar. This could have a negative impact on relationship quality, 39 
because, once a partnership has formed, subsequent cessation of contraceptive use 40 
could lead to realignment of a woman’s preferences and reduction in attraction to her 41 
partner. Indeed, women who are relatively MHC-similar to their partner report 42 
reduced in-pair sexual satisfaction and increased interest in extra-pair relationships 43 
[15]. Even if these effects are subtle, they could have measurable downstream 44 
consequences for relationship quality and likelihood of separation or divorce [9-12]. 45 
 However, other research suggests the potential for positive relationship 46 
outcomes. Under conditions characterized by high progesterone levels and low 47 
fertility (e.g. in the luteal phase or early pregnancy), women express stronger 48 
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preferences for social cues associated with direct benefits of mate choice. Because 49 
some synthetic progestins have similar effects on brain activity and reproductive 50 
behaviour as natural progesterone [16], oral contraceptive users would maintain a 51 
higher level of preference for traits such as wealth and intelligence [17]. Similarly, 52 
weaker preferences for facial masculinity in oral contraceptive users [4-6] could make 53 
for more stable relationships, since men with less masculine features (indicative of 54 
low testosterone levels) are perceived to be [18], and may actually be [19], less likely 55 
to be unfaithful. Thus, this body of research would predict that use of hormonal 56 
contraception during partner choice would be positively associated with women’s 57 
satisfaction with their partner’s support and relationship commitment. 58 
 It is not known whether these laboratory-measured effects on women’s 59 
preferences are sufficiently powerful to influence actual choices that women make in 60 
the real world. Furthermore, it is not known how these two kinds of effects interact in 61 
determining the outcome of the relationship. Because this question is not amenable to 62 
experiment in societies in which women exercise free choice, we here address these 63 
issues using a quasi-experimental design in which we record relationship satisfaction 64 
and survival in a large sample of women who met their partner while they were either 65 
using or not using oral contraception. We collected data from 2519 parous women 66 
about their relationship with their first child’s biological father (hereafter, partner). We 67 
selected women with at least one child to standardize (as far as possible) levels of 68 
relationship commitment and experiences associated with pregnancy and childcare, 69 
and to ensure that women had experienced changes to their hormonal profiles 70 
associated with oral contraceptive use cessation and/or pregnancy during their 71 
relationship. For each woman, we used established scales and items to construct 72 
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composite measures of both sexual and general (nonsexual) satisfaction in the 73 
relationship with her partner.  74 
 75 
 76 
2. MATERIALS AND METHODS 77 
(a) Participants 78 
At the time of partnership formation, 1514 women used no form of hormonal 79 
contraception and 1005 used combined oral contraception. Users of other forms of 80 
hormonal contraception (e.g. progestogen-only pill, implants, injection; n = 278) were 81 
excluded from analyses because these represented a small proportion of the sample 82 
and because these methods differ in hormonal formulation from oral contraceptives 83 
(e.g. they usually employ only progestogens rather than an estrogen/progestogen 84 
combination). Of the 2519 retained participants, 1761 were still in a partnership with 85 
the biological father of their first child. Of the 758 women not still together with the 86 
father, 734 had separated from him or formally divorced (we term both as separation); 87 
the remaining 24 had been bereaved and were excluded from analyses concerning 88 
relationship satisfaction and survival. Average age was 37.7 years (s.d. = 8.6). The 89 
majority of the sample was drawn from the United States (1220) and the Czech 90 
Republic/Slovakia (999); other participants were from the United Kingdom (159), 91 
Canada (98), and other countries (43). Additional analyses (Electronic supplementary 92 
material) confirmed that reported effects were not an artefact of regional variation in 93 
behaviour. 94 
 Participants were recruited via personal contact, by advertisement on 95 
pregnancy and parenthood forum websites, and through social networking websites. 96 
Surveys were completed online. The only criteria for selection were that participants 97 
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should be women with at least one biological child. Most participants from the United 98 
States were drawn from a participant research panel administered by Qualtrics.com. 99 
Czech/Slovak participants were administered the questionnaire in the Czech language. 100 
Participants were told that the study was about their experiences of pregnancy, 101 
children, and their relationship satisfaction, but not the specific hypotheses under test. 102 
The study was approved by the Ethics Committee of the University of Stirling’s 103 
Department of Psychology and conducted according to the principles expressed in the 104 
Declaration of Helsinki. 105 
 106 
(b) Measures  107 
(i) Sexual satisfaction.  108 
Measures of sexual satisfaction were based on those previously used to test effects of 109 
MHC-allele sharing on relationship quality by Garver-Apgar et al. [15]. To construct a 110 
composite measure of sexual satisfaction within their relationship, we recorded 111 
women’s scores on (a) sexual arousal with their partner, (b) partner’s sexual 112 
adventurousness, (c) the frequency with which they experienced orgasm with their 113 
partner during intercourse, (d) sexual attraction to their partner, and (e) sexual 114 
responsiveness to their partner (the sexual proceptivity scale of Ellis’s Partner-Specific 115 
Investment Inventory [20]. Scores were given on anchored 9-point rating scales (e.g. 116 
for sexual arousal, 1 = ‘does not satisfy me at all’, 9 = ‘completely satisfied’). 117 
Correlation analysis show high concordance amongst these five measures (Spearman 118 
rho = 0.42-0.85, see ESM Table 1). Scores on each of these measures were then 119 
normalized and summed.  120 
 121 
(ii) General satisfaction.  122 
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Composite scores of general relationship satisfaction, stressing nonsexual aspects of 123 
the women’s relationship with their partner, were calculated in the same way. We 124 
recorded women’s scores (using 9-point rating scales, as above) to four questions used 125 
by Garver-Apgar et al. [15], measuring the extent to which women were satisfied with 126 
(a) their partner’s provision of financial resources, (b) faithfulness and loyalty, (c) 127 
intelligence, and (d) ambition. In addition, we recorded scores on (e) Brown’s measure 128 
of partner support behaviour [21]. Correlation analysis demonstrated high 129 
concordance amongst these five measures (rho = 0.40-0.57, see ESM Table 2). Scores 130 
for each woman were normalized and summed.  131 
 132 
(iii) Sexual rejection and compliant sex. 133 
We recorded women’s scores on these measures, also following Garver-Apgar et al. 134 
[15]. The sexual rejection score was comprised of three items (e.g. “I rejected my 135 
partner’s attempts to initiate sex”) and the compliant sex score was comprised of two 136 
items (e.g. “had sexual intercourse with my partner even though I didn’t want to 137 
because I felt pressured by his continual arguments”). All items were scored on a 5-138 
point scale, from 1 = ‘never’ to 5 = ‘very often’. Although these measures are to some 139 
degree similar to those included in the sexual satisfaction composite measure, we 140 
analysed them separately because they capture negative aspects of relationship 141 
dynamics and include an element of partner’s coerciveness.  142 
 143 
(iv) Attractiveness of partner. 144 
We also calculated a composite score of women’s assessment of their partner’s 145 
attractiveness. We recorded scores (7-point rating scales, from 1 = ‘much less than 146 
average’ to 7 = ‘much more than average’) on two measures of attractiveness used by 147 
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DeBruine et al. [22] (“compared to other men, how attractive do you consider your 148 
partner’s [face/body] to be”, Spearman rho = 0.62), and Garver-Apgar et al.’s [15] 149 
question “how satisfied are you with your partner’s physical attractiveness” (rho = 150 
0.50 and 0.57, respectively).  151 
 152 
(v) Ratings of ex-partners.  153 
For those couples who had separated, we altered the wording of questions to reflect 154 
this; for example, in place of obtaining levels of agreement with the statement “I feel 155 
strong sexual attraction toward my partner” from Garver-Apgar et al.’s [15] attraction 156 
to partner scale, we used the wording “Thinking back about my ex-partner, I felt 157 
strong sexual attraction towards him”.  158 
 159 
(vi) Experience and attitudes towards extra-pair sex. 160 
To control for individual differences in the participant’s attitudes towards, desire for, 161 
and engagement in extra-pair sex, we used a standard tool, the Sociosexual 162 
Orientation Inventory – Revised (SOI-R) [23]. This comprises three subscales dealing 163 
with past behavioural experiences (e.g. “With how many different partners have you 164 
had sex within the past 12 months?”), attitude toward uncommitted sex (participants 165 
indicate level of agreement with statements such as “I can imagine myself being 166 
comfortable and enjoying “casual” sex with different partners”), and sociosexual 167 
desire (e.g. “How often do you have fantasies about having sex with someone with 168 
whom you do not have a committed romantic relationship?”). Each subscale contains 169 
three items which are summed to yield an overall score. 170 
 171 
(c) Data Analysis 172 
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(i) Relationship satisfaction 173 
Differences in individual measures were first assessed using Mann-Whitney tests. In 174 
order to control for possible confounding differences between groups of women (those 175 
who were using oral contraceptives when they met their partner and those who were 176 
not), we used ANOVA, with dependent variables being measures of relationship 177 
satisfaction. Between-group factors were use of oral contraception/no hormonal 178 
contraception (when couples met) and relationship duration (split by the median 179 
relationship length because of skew in this variable). In addition, sociosexuality (SOI-180 
R score) was included in the model as a covariate. Sample sizes vary because some 181 
women did not respond to all items. 182 
 183 
(ii) Relationship outcome 184 
We first used chi-square tests to test for associations between outcome measures 185 
(women’s responsibility for initiation of separation, absolute rates of separation) and 186 
women’s use of oral contraception when couples met. Subsequently, we used logistic 187 




3. RESULTS 192 
(a) Relationship satisfaction 193 
Amongst women whose relationship was ongoing (n = 1761), initial analysis revealed 194 
several statistically significant differences between women who were using or not 195 
using oral contraception when they met their partner (Table 1). Women who used oral 196 
contraception during partner choice (compared with non-users) scored lower on sexual 197 
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arousal with their partner, on satisfaction with his sexual adventurousness, and on 198 
sexual proceptivity and attraction towards him. They also rated their partner’s body 199 
lower in attractiveness compared to non-users. In contrast, these women appeared 200 
more satisfied with general (non-sexual) aspects of their partner: they were 201 
significantly more satisfied with his financial provision compared with women who 202 
were not using oral contraception during partner choice, and they appeared to be more 203 
satisfied with his intelligence and support (although these did not achieve statistical 204 
significance, p = 0.051 and 0.058, respectively). 205 
 Although the results of this initial analysis are consistent with predictions 206 
generated by a body of laboratory studies (reviewed above) that suggest that oral 207 
contraceptive use might alter mate preferences, it is possible that some or all of these 208 
effects could alternatively arise as a result of between-group differences that are 209 
unrelated to mate choice and any disruptive effects of oral contraception. For example, 210 
lower sexual satisfaction associated with oral contraceptive use could instead be due to 211 
differences in attitudes towards, or willingness to engage in, uncommitted, short-term 212 
relationships (sociosexuality). Time since partnership formation is also likely to 213 
influence relationship satisfaction [24]. Responses to satisfaction measures might also 214 
be influenced by hormonal condition. We therefore carried out additional confirmatory 215 
analyses using ANOVA to control for these variables. We included SOI-R scores as a 216 
covariate, relationship duration as a factor, and we accounted for the possibility that 217 
current hormonal condition contributes to women’s perception of their partner by 218 
excluding women who were pregnant or using hormonal contraception during data 219 
collection (the corresponding analysis, including only current oral contraceptive users, 220 
retained too few individuals to generate sufficient statistical power). In the analysis of 221 
sexual satisfaction and partner attractiveness, we also included general relationship 222 
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satisfaction as a covariate since this could influence within-couple sexual satisfaction 223 
and capture further unspecified aspects of partnership satisfaction that might vary 224 
between groups (sexual and general satisfaction were positively correlated, r = 0.600, 225 
P < 0.0001). In this analysis (Fig.1a), we again found significantly lower sexual 226 
satisfaction in women who were using oral contraception when they met their partner 227 
(F1,1200 = 7.57, P = 0.006), despite scoring higher in terms of general satisfaction 228 
(F1,1206 = 10.07, P = 0.002). Women also scored their partner as less attractive (F1,1203 229 
= 13.98, P < 0.001) if they met while using oral contraception. 230 
Other measures of sexual satisfaction [15] include the frequency of a woman’s 231 
acquiescence to sex under pressure from her partner (compliant sex) or with which she 232 
rejects her partner’s sexual advances. After controlling for sociosexuality, general 233 
relationship satisfaction and current hormonal condition, we found significant 234 
interactions between oral contraceptive use during partner choice and relationship 235 
length (Fig.2): women who used oral contraceptives rejected sex (F1,1204 = 8.08, P = 236 
0.005) and engaged in compliant sex (F1,1204 = 6.12, P = 0.014) less frequently than 237 
non-users if the relationship was relatively new, but did so more frequently in longer 238 
relationships. This interaction appears to explain why neither of these measures 239 
approach statistical significance in the raw dataset (Table 1). 240 
 241 
(b) Ex-partners and initiation of separation 242 
Women no longer with their partner retrospectively assessed the same relationship 243 
attributes (Fig.1b). Amongst these women, there was no relationship between oral 244 
contraceptive use during partner choice and recalled general relationship satisfaction 245 
(P = 0.41), or frequencies of compliant sex (P = 0.16) and sexual rejection (P = 0.18). 246 
However, women who used oral contraceptives during partner choice recalled being 247 
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less sexually satisfied (again, controlling for general satisfaction; F1,724 = 5.52, P = 248 
0.019) and rated their ex-partner as less attractive (F1,727 = 5.02, P = 0.025), compared 249 
with non-users, consistent with the women whose relationship was ongoing.  250 
 251 
(c) Relationship outcome  252 
Finally, we examined whether oral contraceptive use during partner choice was 253 
associated with relationship outcome. Women who used oral contraceptives during 254 
partner choice were disproportionately likely to have initiated the separation if it 255 
occurred (84.8%: 196/231 of separations were initiated by the woman rather than the 256 
male partner, excluding 6 where the woman reported equal responsibility between 257 
partners) compared with non-users (73.6%: 349/474, excluding 23 women who 258 
reported equal responsibility) (Chi-square = 11.14, d.f. = 1, P = 0.001). This effect 259 
remained significant (logistic regression: exp B= 0.495, P = 0.001) after controlling 260 
for women’s age (exp B = 1.0, P = 0.71) and sociosexuality (exp B = 1.10, P = 0.46).  261 
However, despite this, we found that separation rate was lower if the woman 262 
was using oral contraception during partner choice (Fig.3a): 237 of 1004 such couples 263 
(23.6%) had separated, compared with 497 of 1491 couples (33.3%) in which women 264 
were not using hormonal contraception (Chi-square = 27.34, d.f. = 1, P < 0.0001). A 265 
logistic regression analysis, controlling for age and sociosexuality, confirmed that 266 
couples were less likely to have separated if the woman used oral contraception during 267 
partner choice (exp B = 0.62, P < 0.0001), and that this was independent of the effects 268 
of sociosexuality (exp B = 2.06, P < 0.0001) and age (exp B = 1.06, P < 0.0001). 269 
Furthermore, amongst relationships that ended in separation, partnership duration was 270 
longer when the woman used oral contraception during partner choice (Fig.3b; z = 271 
3.39, P = 0.001), by two years on average (median relationship length: 60 and 84 272 
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months for non-users and users, respectively). This difference was robust to exclusion 273 
of outliers and extreme values (defined as scores of between 1.5 and 3 times the inter-274 
quartile range, or more than 3 times the inter-quartile range), with median relationship 275 
duration then being 60 and 81 months for non-users and oral contraceptive users, 276 
respectively (z = 3.50, P < 0.001). Confirmatory analyses (Electronic supplementary 277 
material) showed that these effects are unlikely to be due to a higher rate of unplanned 278 
pregnancy amongst non-users. 279 
 280 
 281 
4. DISCUSSION 282 
Our results indicate that a woman’s use of oral contraception at the time when she 283 
meets her partner has measurable downstream consequences for partnership outcome. 284 
The lower satisfaction with sexual aspects of the relationship and reduced attraction to 285 
the primary partner that we report amongst women who met their partner while using 286 
oral contraception are consistent with previous laboratory studies that indicate that oral 287 
contraception might interfere with adaptive preferences, such as preference for MHC-288 
dissimilar men. Compared with normally cycling women, oral contraceptive users 289 
prefer body odours of relatively MHC-similar men [8] and initiation of oral 290 
contraceptive use shifts these preferences towards MHC-similarity [9]. Furthermore, 291 
in couples who are relatively MHC-similar, women express lower sexual satisfaction 292 
with their partner and higher interest in extra-pair sex [15]. Although the possibility 293 
that disruption of preferences by oral contraception influences relationship outcome 294 
has been the subject of considerable conjecture [9-12, 25, 26], our results provide the 295 
first evidence for this outside of the laboratory, in actual long-term partnerships. 296 
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 However, as predicted, the results also reveal that women who used oral 297 
contraceptives during partner choice were more satisfied with nonsexual aspects of 298 
their relationship, including the partner’s financial provision, faithfulness, and support. 299 
Based on previous studies, we think it likely that this could arise through the 300 
suppression by oral contraceptive use of periovulatory increases in preference for 301 
putative markers of good genes, such as masculinity or dominance, that are evident in 302 
women with normal menstrual cycles [1-4, 27,28], thus leading to a maintained 303 
preference (during a woman’s actual partner choice) for markers of high-quality 304 
paternal investment that characterizes low fertility phases of the menstrual cycle [17-305 
19, 29].  306 
In combination, these effects mean that there may be both negative and 307 
positive associations between oral contraceptive use during partner choice and 308 
subsequent relationship satisfaction. Interpreting the interplay between them, we 309 
suggest that, on average, higher general (nonsexual) relationship satisfaction in 310 
women who meet their partner while using oral contraception might ameliorate or 311 
outweigh the concomitant effects of reduced sexual satisfaction. Additionally, a 312 
maintained preference for traits indicating high paternal investment may mean that, on 313 
average, the men chosen by women using oral contraception are less disposed to seek 314 
separation. Together, this could explain our finding of longer relationships in couples 315 
who met while the woman used oral contraception.  316 
However, as relationships progress there may potentially come a tipping point 317 
at which a woman’s sexual dissatisfaction outweighs nonsexual satisfaction. Evidence 318 
for this includes the finding that, among women using oral contraception during 319 
partner choice, sexual dissatisfaction (compliant sex, sexual rejection) intensifies in 320 
relatively long relationships, while there was no change in non-users. Furthermore, 321 
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there was a relatively small difference in recalled general satisfaction between former 322 
users and non-users who had separated compared with the large difference in those 323 
still together, indicating that sustained levels of general satisfaction may be important 324 
for relationship survival. If changes in the balance between sexual and general 325 
satisfaction contribute to the incidence of separation, women who used oral 326 
contraception during partner choice may be more likely than non-users to be 327 
responsible for initiating eventual separation. Our results support this conjecture. 328 
While it is well-established that women (rather than their male partners) generally 329 
initiate separation [30-31], we found that women who used oral contraception during 330 
partner choice were even more likely to initiate the separation (if it occurred) than 331 
women who had not. 332 
We have hypothesised that the reported effects are due to effects of oral 333 
contraception on women’s partner choice, but it is also possible that oral contraceptive 334 
use during relationships may also contribute to relationship satisfaction and outcome. 335 
For example, differences in contraceptive use at the point of partner choice might also 336 
reflect patterns of use after relationships are established. If so, it is possible that 337 
suppression of cyclical preference shifts by oral contraceptives could lead to 338 
stabilisation of relationship satisfaction in both male and female partners during the 339 
relationship, in addition to the proposed effects on initial mate choice. Thus, women 340 
who use oral contraceptives during the relationship would not experience mid-cycle 341 
shifts in desire for attributes that might not be possessed by her partner, and men may 342 
not experience changes in concern with partner fidelity or attractiveness (for a review 343 
of such issues, see [2]). In this way, the association between oral contraceptive use and 344 
initiation of relationship dissolution by women might alternatively be interpreted in 345 
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terms of higher initiation by men whose partner is a non-user. The distinction between 346 
these ideas remains a point for further research.  347 
 Furthermore, although our results are consistent with the idea that oral 348 
contraception may alter adaptive mate choice, with downstream consequences on 349 
relationship satisfaction and outcome, it remains possible that any of the reported 350 
effects may alternatively arise from other, as yet undetermined, associations between 351 
oral contraceptive use and relationship satisfaction. However, we controlled for 352 
several likely candidates. First, there may be differences between users and non-users 353 
in attitudes towards sex and behaviour in sexual relationships, which we controlled for 354 
using the sociosexual orientation index. It is also noteworthy that the interactions 355 
between contraceptive use and relationship duration (Fig.2, showing that women using 356 
oral contraception during partner choice were initially less likely to reject sex or 357 
acquiesce to sex under pressure from their partner, but became increasingly likely to 358 
do so, relative to non-users, as relationships progressed) demonstrate that relative 359 
sexual satisfaction cannot be simply explained by previous use or non-use of oral 360 
contraception. Second, assessment of current relationship satisfaction may be 361 
influenced by current hormonal state, but we controlled for this in the relevant 362 
analyses by excluding women using oral contraception and those who were pregnant 363 
at the time of the survey. Third, in analyses probing sexual satisfaction, we controlled 364 
for the effects of non-sexual aspects of relationship quality, including financial 365 
provision and partner support. Fourth, we controlled for the duration of the 366 
relationship. Finally, we checked that the reported effects held in two different 367 
populations (the US and the Czech/Slovak populations) and that they were not 368 
explained by between-group differences in commitment to the relationship potentially 369 
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induced by a higher frequency of unplanned pregnancy amongst the non-users (see 370 
ESM).  371 
In summary, after controlling for these possible confounds, we found that 372 
women who met their partner while using oral contraception were more satisfied in the 373 
nonsexual aspects of their relationship with their partner. This is consistent with 374 
studies showing that women express stronger preferences for social cues associated 375 
with direct benefits of mate choice at times of high progesterone levels and low 376 
fertility. However, these benefits appear to be offset by costs in terms of lower 377 
satisfaction in sexual aspects of the relationship. Women who used oral contraception 378 
when they met their partner tended to find him less attractive, engaged in compliant 379 
sex and rejected sexual advances more frequently as the relationship progressed, and 380 
were more likely to initiate separation if it occurred. Although we do not know the 381 
relative degree of genetic similarity between couples in this study, these effects are 382 
also consistent with studies investigating mate preference for genetically 383 
complementary partners. For each kind of effect, our results suggest that these 384 
previously-described mate preferences are not restricted to the laboratory but are also 385 
expressed in actual partner choices. More importantly, our data also provide evidence 386 
that suppression of cyclical preference shifts by oral contraceptive use may disrupt the 387 
expression of these adaptive preferences. We stress that the nature of this research 388 
question precludes a true experimental approach and that we therefore remain cautious 389 
about the causational link behind the associations we describe. We also recognise that 390 
the reasons for any relationship’s survival or dissolution are complex and not limited 391 
to contraceptive choice at its inception. Nonetheless, our data provide important 392 
evidence in support of the proposal that the use of oral contraception during partner 393 
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choice (and possibly beyond) has the potential to profoundly influence the outcome of 394 
long-term relationships.  395 
 396 
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Figure Legends 493 
 494 
Figure 1. Measures of relationship satisfaction in women who met their partner while 495 
either using or not using oral contraceptives. Data show estimated marginal means of 496 
standardized scores (± s.e.m), adjusted for SOI-R score, relationship duration, and 497 
current hormonal condition. Estimates of sexual satisfaction and partner attractiveness 498 
also control for general (nonsexual) relationship satisfaction. (a) Women still in a 499 
current relationship with the biological father of their first child (749 were non-users 500 
and 462 were oral contraceptive (OC) users at time of meeting). (b) Retrospective 501 
scores of women no longer in a relationship with the father of their first child (492 502 
were non-users and 236 were OC users at time when couples met). Significant 503 
differences are indicated by * (P < 0.05) and ** (P < 0.01). 504 
 505 
Figure 2. Relative frequency with which women rejected sex with their partner, or 506 
undertook compliant sex with him, in still-partnered women who met their partner 507 
while either using oral contraception (OC) (n=461) or not (n=749). Data are estimated 508 
marginal means (± s.e.m), adjusted for SOI-R score, general relationship satisfaction 509 
and current hormonal condition. Both interactions are statistically significant (sexual 510 
rejection: P = 0.005; compliant sex: P = 0.014). Short and Long refer to current 511 
relationship duration, split by the median relationship length of 142 months. 512 
 513 
Figure 3. Effects of oral contraceptive use at the time of partner choice on relationship 514 
outcome. (a) Frequency of separation is lower amongst women using oral 515 
contraception (OC) when they met the biological father of their first child, compared 516 
to those who were not (P < 0.0001). (b) Relationship duration is longer (P = 0.001) 517 
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amongst women who were using oral contraceptives when couples met (analysis 518 
includes only separated couples). Horizontal lines are median number of months, 519 
boxes indicate inter-quartile range. Circles and triangles represent outliers and extreme 520 
values, respectively. Both analyses control for women’s age and SOI-R score. The 521 
difference in (b) was robust to exclusion of outliers (O) and extreme values (Δ) (P < 522 
0.001).  523 
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Sexual satisfaction        
Sexual arousal 6.07 ± 0.062 5.91 ± 0.068 991 766 2.34 0.020 
Sexual adventurousness 5.82 ± 0.064 5.62 ± 0.071 990 765 2.52 0.012 
Sexual proceptivity  3.80 ± 0.026 3.72 ± 0.028 993 766 2.84 0.005 
Sexual attraction 3.35 ± 0.034 3.20 ± 0.037 990 765 3.20 0.001 
Orgasm with partner 3.82 ± 0.040 3.79 ±  0.044 991 762 0.99 0.32 
       
General satisfaction       
Financial provision 5.74 ± 0.064 6.02 ± 0.067 991 766 2.60 0.009 
Faithfulness/loyalty 6.79 ± 0.051 6.84 ± 0.058 992 765 0.46 0.64 
Intelligence 6.80 ± 0.046 6.96 ± 0.047 992 766 1.95 0.051 
Ambition 5.89 ± 0.059 5.87 ± 0.064 991 764 0.80 0.42 
Support 4.51 ± 0.035 4.45 ± 0.037  993 766 1.89 0.058 
       
Other measures       
Partner rejection 2.03 ± 0.030 2.02 ± 0.032 992 765 0.53 0.59 
Compliant sex 1.46 ± 0.026 1.40 ± 0.027 993 765 0.92 0.36 
Facial attractiveness 5.01 ± 0.038 4.98 ± 0.038 992 767 0.41 0.68 
Body attractiveness 4.69 ± 0.043  4.53 ± 0.047 991 765 2.46 0.014 
1
In this table, oral contraceptive (OC) use is at time of meeting partner, irrespective of current usage (in-
text additional analyses control for current usage) 
2
Note that sample sizes vary slightly across measures as a small number of women refrained from 
answering certain questions 
3
Statistical analyses used non-parametric Mann-Whitney tests; mean rating scores (± standard error) are 
shown for ease of interpretation. Statistically significant comparisons are highlighted in bold 
 
 
